← ALD resources

ALD glossary

When you hear a new word, you deserve an explanation that makes sense. Search for a term or explore by topic.

AMNL score

A scoring system studied in confirmed X-linked ALD that records adrenal insufficiency, myelopathy, neuropathy and leukodystrophy separately.

More detail

The published system was not validated for people with a variant of uncertain significance. It does not predict an individual’s future.

Also listed as AMNL scoring system, A M N L

Related terms

Sources

Link to this term

Carrier terminology

A term some people have used for women with a disease-causing ABCD1 variant.

More detail

International ALD recommendations favor describing women with ALD by whether they have symptoms, since women can experience health effects.

Also listed as carrier, female carrier, ALD carrier

Related terms

Sources

Link to this term

Gadolinium contrast and enhancement

A gadolinium-based contrast agent can make some MRI findings easier to see. Enhancement means an area changes in appearance after contrast.

More detail

Gd-negative means no enhancement was seen after gadolinium contrast. A single scan without enhancement cannot establish stability over time.

Also listed as gadolinium

Related terms

Sources

Link to this term

Leriglitazone (Nezglyal)

A medicine authorized in the European Union for a defined group of boys with cerebral ALD.

More detail

The EU authorized it under exceptional circumstances for boys ages 2–12 with brain lesions that do not enhance with gadolinium and a Neurologic Function Score of 0 or 1. Check the regulator and your care team for the exact indication and local availability.

Also listed as Nezglyal, leriglitazone

Related terms

Sources

Link to this term

Out-of-range newborn screen

A screening result outside the program’s expected range that needs follow-up.

More detail

An out-of-range or positive screen is not a diagnosis. A borderline result is a separate result category in some programs, and a repeat screen is a follow-up step. Follow the timing the screening team gives you.

Also listed as positive screen

Related terms

Sources

Link to this term

Primary adrenal insufficiency

When the adrenal glands themselves cannot make enough hormones, including cortisol.

More detail

You may hear Addison’s disease used for primary adrenal insufficiency. In ALD, adrenal problems may be the first or only sign at the time of diagnosis.

Also listed as PAI, Addison disease, Addison’s disease

Related terms

Sources

Link to this term

Skysona (elivaldogene autotemcel)

A gene therapy made from a person’s own blood-forming stem cells to slow neurological decline in a defined group of boys with cerebral ALD.

More detail

The U.S. indication is for boys ages 4–17 with early, active cerebral ALD who lack an available HLA-matched donor for a stem cell transplant. The FDA label has a boxed warning about blood cancers and calls for lifelong monitoring.

Also listed as Skysona, eli-cel, elivaldogene autotemcel

Related terms

Sources

Link to this term

This glossary is educational. It was checked against the listed sources and has not undergone independent medical specialist review. Ask your own care team about individual results and care. International ALD recommendations